Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsWith over a decade of experience in phage display technology, Creative Biolabs can provide a series of antibody or peptide libraries that are available for licensing or direct screening. These ready-to-use libraries are invaluable resources for isolating target-specific binders for various research, diagnostic or therapeutic applications. Highlights
Creative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
HighlightsExcitatory amino acid transporter 2 (EAAT2), also known as solute family 1 member 2 (SLC1A2) and glutamate transporter 1 (GLT-1), is a protein encoded by the SLC1A2 gene in humans. There are spliced transcript variants of SLC1A2, but their intact nature is unclear.
| Basic Information of SLC1A2 | |
| Protein Name | Excitatory amino acid transporter 2 (EAAT2) |
| Gene Name | SLC1A2 |
| Aliases | Glutamate/aspartate transporter II, Sodium-dependent glutamate/aspartate transporter 2, Solute carrier family 1 member 2 |
| Organism | Homo sapiens (Human) |
| UniProt ID | P43004 |
| Transmembrane Times | 8 |
| Length (aa) | 574 |
| Sequence | MASTEGANNMPKQVEVRMHDSHLGSEEPKHRHLGLRLCDKLGKNLLLTLTVFGVILGAVCGGLLRLASPIHPDVVMLIAFPGDILMRMLKMLILPLIISSLITGLSGLDAKASGRLGTRAMVYYMSTTIIAAVLGVILVLAIHPGNPKLKKQLGPGKKNDEVSSLDAFLDLIRNLFPENLVQACFQQIQTVTKKVLVAPPPDEEANATSAVVSLLNETVTEVPEETKMVIKKGLEFKDGMNVLGLIGFFIAFGIAMGKMGDQAKLMVDFFNILNEIVMKLVIMIMWYSPLGIACLICGKIIAIKDLEVVARQLGMYMVTVIIGLIIHGGIFLPLIYFVVTRKNPFSFFAGIFQAWITALGTASSAGTLPVTFRCLEENLGIDKRVTRFVLPVGATINMDGTALYEAVAAIFIAQMNGVVLDGGQIVTVSLTATLASVGAASIPSAGLVTMLLILTAVGLPTEDISLLVAVDWLLDRMRTSVNVVGDSFGAGIVYHLSKSELDTIDSQHRVHEDIEMTKTQSIYDDMKNHRESNSNQCVYAAHNSVIVDECKVTLAANGKSADCSVEEEPWKREK |
SLC1A2 is a member of the solute family of protein families. Membrane-binding proteins are the major transporters of excitatory neurotransmitters in the extrasynaptic space of the central nervous system. Glutamate clearance is necessary for proper synaptic activation and can prevent nerve damage from excessive activation of glutamate receptors. SLC1A2 is responsible for more than 90% of glutamate reuptake in the brain. Mutation and reduced expression of this protein is associated with amyotrophic lateral sclerosis (ALS). The drug riluzole is approved for the treatment of ALS upregulates SLC1A2. Ceftriaxone, an antibiotic, has been shown to induce/enhance the expression of SLC1A2, thereby reducing glutamate activity. Ceftriaxone has been shown to reduce the development and expression of resistance to opioids and other drugs of abuse. SLC1A2 may play an important role in drug addiction and tolerance to addictive drugs. Upreg regulation of SLC1A2 (GLT-1) causes damage to prepulse inhibition, and sensory control defects exist in animal models of schizophrenia and schizophrenia. Some antipsychotic drugs have been shown to reduce the expression of SLC1A2.
Fig.1 The structure of SLC1A2 protein.
These results suggest that individual dot methylation in the SLC1A2 promoter region may be altered by exogenous addiction and may develop clinically valuable epigenetic biomarkers for BD diagnosis and monitoring.
These findings are exploratory in nature and awaiting replication in larger populations, however, they provide interesting evidence that potential functional rare variations in the SLC1A2 gene may lead to susceptibility to mental illness.
These results support the fact that SLC1A2 is perhaps a good functional candidate gene for ET.
These findings confirm the key role of serine 364, hydroxyl group of which is key to couple sodium and substrate flux.
These findings do not support the susceptibility of SLC1A2 rs3764087 to ET in the North American population.
To obtain the soluble and functional target protein, the versatile Magic™ membrane protein production platform in Creative Biolabs enables many flexible options, from which you can always find a better match for your particular project. Aided by our versatile Magic™ anti-membrane protein antibody discovery platform, we also provide customized anti-SLC1A2 antibody development services.
Creative Biolabs' skillful scientists are glad to leverage our expertise and advanced technologies to help you with the member protein research. If you are interested, please feel free to contact us for more details.
All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
